2,011
Views
52
CrossRef citations to date
0
Altmetric
Perspective

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference

, &
Pages 1131-1141 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Simin Wen, Zhengyu Wu, Shuyi Zhong, Mao Li & Yuelong Shu. (2021) Factors influencing the immunogenicity of influenza vaccines. Human Vaccines & Immunotherapeutics 17:8, pages 2706-2718.
Read now
Kristin G.-I. Mohn, Ingrid Smith, Haakon Sjursen & Rebecca Jane Cox. (2018) Immune responses after live attenuated influenza vaccination. Human Vaccines & Immunotherapeutics 14:3, pages 571-578.
Read now
Constantina Boikos, Jesse Papenburg, Christine Martineau, Lawrence Joseph, David Scheifele, Mark Chilvers, Larry C. Lands, Gaston De Serres & Caroline Quach. (2017) Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis. Human Vaccines & Immunotherapeutics 13:6, pages 1254-1260.
Read now
Irina Isakova-Sivak & Larisa Rudenko. (2015) Safety, immunogenicity and infectivity of new live attenuated influenza vaccines. Expert Review of Vaccines 14:10, pages 1313-1329.
Read now
Kathleen L Coelingh, Catherine J Luke, Hong Jin & Kawsar R Talaat. (2014) Development of live attenuated influenza vaccines against pandemic influenza strains. Expert Review of Vaccines 13:7, pages 855-871.
Read now
Seth L Toback, Myron J Levin, Stan L Block, Robert B Belshe, Christopher S Ambrose & Judith Falloon. (2012) Quadrivalent Ann Arbor strain live-attenuated influenza vaccine. Expert Review of Vaccines 11:11, pages 1293-1303.
Read now
Philip Dormitzer, Theodore Tsai & Giuseppe Del Giudice. (2012) New technologies for influenza vaccines. Human Vaccines & Immunotherapeutics 8:1, pages 45-58.
Read now

Articles from other publishers (45)

Lindsay Hill-Batorski, Yasuko Hatta, Michael J. Moser, Sally Sarawar, Gabriele Neumann, Yoshihiro Kawaoka & Pamuk Bilsel. (2023) Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge. Vaccines 11:4, pages 798.
Crossref
Richard Pebody & Kanta Subbarao. 2023. Plotkin's Vaccines. Plotkin's Vaccines 552 576.e8 .
Alice Mannocci, Andrea Pellacchia, Rossella Millevolte, Manuela Chiavarini & Chiara de Waure. (2022) Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials. International Journal of Environmental Research and Public Health 19:15, pages 9425.
Crossref
Kanta Subbarao. (2021) Live Attenuated Cold-Adapted Influenza Vaccines. Cold Spring Harbor Perspectives in Medicine 11:9, pages a038653.
Crossref
Andrew Chak-Yiu Lee, Anna Jinxia Zhang, Can Li, Yanxia Chen, Feifei Liu, Yan Zhao, Hin Chu, Carol Ho-Yan Fong, Pui Wang, Siu-Ying Lau, Kelvin Kai-Wang To, Honglin Chen & Kwok-Yung Yuen. (2021) Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges. npj Vaccines 6:1.
Crossref
Yorissa Padayachee, Sabine Flicker, Sophia Linton, John Cafferkey, Onn Min Kon, Sebastian L. Johnston, Anne K. Ellis, Martin Desrosiers, Paul Turner, Rudolf Valenta & Glenis Kathleen Scadding. (2021) Review: The Nose as a Route for Therapy. Part 2 Immunotherapy. Frontiers in Allergy 2.
Crossref
G. Landgraf, Y.A. Desheva & L.G. Rudenko. (2021) Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines. Virus Research 300, pages 198396.
Crossref
Meghan E. Rebuli, Ellen Glista-Baker, Jessica R. Hoffman, Parker F. Duffney, Carole Robinette, Adam M. Speen, Erica A. Pawlak, Radhika Dhingra, Terry L. Noah & Ilona Jaspers. (2021) Electronic-Cigarette Use Alters Nasal Mucosal Immune Response to Live-attenuated Influenza Virus. A Clinical Trial. American Journal of Respiratory Cell and Molecular Biology 64:1, pages 126-137.
Crossref
Hye-Rin Jeong, Joon-Yong Bae, Jee-Hyun Park, Seung-Ki Baek, Gayeong Kim, Man-Seong Park & Jung-Hwan Park. (2020) Preclinical study of influenza bivalent vaccine delivered with a two compartmental microneedle array. Journal of Controlled Release 324, pages 280-288.
Crossref
Arnold S Monto. (2020) Effectiveness of the Live Attenuated Influenza Vaccine: Was the Addition of the Second Type B Lineage a Step Too Far?. Clinical Infectious Diseases 70:12, pages 2514-2516.
Crossref
David Jackson, Max Pitcher, Chris Hudson, Nick Andrews, Jo Southern, Joanna Ellis, Katja Höschler, Richard Pebody, Paul J Turner, Elizabeth Miller & Maria Zambon. (2020) Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom. Clinical Infectious Diseases 70:12, pages 2505-2513.
Crossref
Ian Shannon, Chantelle L White & Jennifer L Nayak. (2020) Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine. Journal of the Pediatric Infectious Diseases Society 9:Supplement_1, pages S10-S14.
Crossref
Raburn M. Mallory, Andrew Nyborg, Rubana N. Kalyani, Yuan Yuan, Stan L. Block & Filip Dubovsky. (2020) A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24–<48 months of age. Vaccine 38:5, pages 1001-1008.
Crossref
Barbara Holzer, Sophie B. Morgan, Veronica Martini, Rajni Sharma, Becky Clark, Christopher Chiu, Francisco J. Salguero & Elma Tchilian. (2019) Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs. Frontiers in Immunology 10.
Crossref
Benjamin B Lindsey, Ya Jankey Jagne, Edwin P Armitage, Anika Singanayagam, Hadijatou J Sallah, Sainabou Drammeh, Elina Senghore, Nuredin I Mohammed, David Jeffries, Katja Höschler, John S Tregoning, Adam Meijer, Ed Clarke, Tao Dong, Wendy Barclay, Beate Kampmann & Thushan I de Silva. (2019) Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study. The Lancet Respiratory Medicine 7:8, pages 665-676.
Crossref
Huixiao Yang, Zhonghai Yan, Zijian Zhang, Adilene Realivazquez, Binger Ma & Yi Liu. (2019) Anti-caries vaccine based on clinical cold-adapted influenza vaccine: A promising alternative for scientific and public-health protection against dental caries. Medical Hypotheses 126, pages 42-45.
Crossref
Rajeev Rudraraju, Francesca Mordant & Kanta Subbarao. (2019) How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines. The Journal of Infectious Diseases 219:Supplement_1, pages S81-S87.
Crossref
Larisa Rudenko, Irina Kiseleva, Elena Krutikova, Ekaterina Stepanova, Andrey Rekstin, Svetlana Donina, Maria Pisareva, Elena Grigorieva, Kirill Kryshen, Arman Muzhikyan, Marina Makarova, Erin Grace Sparrow, Guido Torelli & Marie-Paule Kieny. (2018) Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. PLOS ONE 13:12, pages e0208028.
Crossref
Leena R. Yeolekar, Milan Ganguly, Parikshit Tyagi, Nilesh B. Ingle, Koert J. Stittelaar, Leon de Waal, Francesco Berlanda Scorza, Kutub Mahmood & Rajeev M. Dhere. (2018) Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains. Vaccine 36:46, pages 6944-6952.
Crossref
Sarah A. Buchan, Stephanie Booth, Allison N. Scott, Kimberley A. Simmonds, Lawrence W. Svenson, Steven J. Drews, Margaret L. Russell, Natasha S. Crowcroft, Mark Loeb, Bryna F. Warshawsky & Jeffrey C. Kwong. (2018) Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada. JAMA Pediatrics 172:9, pages e181514.
Crossref
Svetlana Shcherbik, Paul Carney, Nicholas Pearce, James Stevens, Vivien G. Dugan, David E. Wentworth & Tatiana Bousse. (2018) Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines. Virology 522, pages 65-72.
Crossref
Sinthujan Jegaskanda, Rosemarie D. Mason, Sarah F. Andrews, Adam K. Wheatley, Ruijun Zhang, Glennys V. Reynoso, David R. Ambrozak, Celia P. Santos, Catherine J. Luke, Yumiko Matsuoka, Jason M. Brenchley, Heather D. Hickman, Kawsar R. Talaat, Sallie R. Permar, Hua-Xin Liao, Jonathan W. Yewdell, Richard A. Koup, Mario Roederer, Adrian B. McDermott & Kanta Subbarao. (2018) Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes. Journal of Virology 92:9.
Crossref
Rita Czakó, Leatrice Vogel, Troy Sutton, Yumiko Matsuoka, Florian Krammer, Zhongying Chen, Hong Jin & Kanta Subbarao. (2018) H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets. Vaccine 36:14, pages 1871-1879.
Crossref
Richard Pebody, Jim McMenamin & Hanna Nohynek. (2018) Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere. Archives of Disease in Childhood 103:1, pages 101-105.
Crossref
Michelle A Gill & Elizabeth P Schlaudecker. (2017) Perspectives from the Society for Pediatric Research: Decreased Effectiveness of the Live Attenuated Influenza Vaccine. Pediatric Research 83:1, pages 31-40.
Crossref
Catherine J. Luke, Seema S. Lakdawala & Kanta Subbarao. 2018. Plotkin's Vaccines. Plotkin's Vaccines 489 510.e7 .
Kristin G. I. Mohn, Fan Zhou, Karl A. Brokstad, Saranya Sridhar & Rebecca J. Cox. (2017) Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination. The Journal of Infectious Diseases 215:10, pages 1527-1535.
Crossref
Richard Pebody, Fiona Warburton, Joanna Ellis, Nick Andrews, Alison Potts, Simon Cottrell, Jillian Johnston, Arlene Reynolds, Rory Gunson, Catherine Thompson, Monica Galiano, Chris Robertson, Rachel Byford, Naomh Gallagher, Mary Sinnathamby, Ivelina Yonova, Sameera Pathirannehelage, Matthew Donati, Catherine Moore, Simon de Lusignan, Jim McMenamin & Maria Zambon. (2016) Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Eurosurveillance 21:38.
Crossref
Kristin Greve-Isdahl Mohn, Karl Albert Brokstad, Rishi D. Pathirana, Geir Bredholt, Åsne Jul-Larsen, Mai Chi Trieu, Sarah Larteley Lartey, Emanuele Montemoli, Camilla Tøndel, Hans Jørgen Aarstad & Rebecca Jane Cox. (2016) Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils. Journal of Infectious Diseases 214:5, pages 722-731.
Crossref
Svetlana Shcherbik, Nicholas Pearce, Irina Kiseleva, Natalie Larionova, Larisa Rudenko, Xiyan Xu, David E. Wentworth & Tatiana Bousse. (2016) Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses. Journal of Virological Methods 227, pages 33-39.
Crossref
Mariana Baz, Kobporn Boonnak, Myeisha Paskel, Celia Santos, Timothy Powell, Alain Townsend & Kanta Subbarao. (2015) Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge. mBio 6:5.
Crossref
Rita Czako & Kanta Subbarao. (2015) Refining the approach to vaccines against influenza A viruses with pandemic potential. Future Virology 10:9, pages 1033-1047.
Crossref
YanChun Peng, Beibei Wang, Kawsar Talaat, Ruth Karron, Timothy J. Powell, Hui Zeng, Danning Dong, Catherine J. Luke, Andrew McMichael, Kanta Subbarao & Tao Dong. (2015) Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination. Frontiers in Immunology 6.
Crossref
K. G.- I. Mohn, G. Bredholt, K. A. Brokstad, R. D. Pathirana, H. J. Aarstad, C. Tondel & R. J. Cox. (2014) Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children. Journal of Infectious Diseases 211:10, pages 1541-1549.
Crossref
Viroj WiwanitkitÅsne Jul-Larsen & Rebecca Jane Cox. 2015. Current Issues with Influenza Management. Current Issues with Influenza Management 110 129 .
Andrew J. Broadbent, Celia P. Santos, Myeisha Paskel, Yumiko Matsuoka, Janine Lu, Zhongying Chen, Hong Jin & Kanta Subbarao. (2015) Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates. Vaccine 33:1, pages 193-200.
Crossref
Emily P. Wen, Ronald Ellis & Narahari S. PujarBernd Kalbfuss‐Zimmermann & Udo Reichl. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing 97 180 .
Jacco Heldens, Ellen Hulskotte, Theo Voeten, Belinda Breedveld, Pierre Verweij, Wilbert van Duijnhoven, Larissa Rudenko, Pierre van Damme & Han van den Bosch. (2014) Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers. Vaccine 32:39, pages 5118-5124.
Crossref
Yo Jang & Baik Seong. (2014) Options and Obstacles for Designing a Universal Influenza Vaccine. Viruses 6:8, pages 3159-3180.
Crossref
Hyun-Mi Pyo & Yan Zhou. (2014) Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection. Vaccine 32:30, pages 3835-3842.
Crossref
Yo Han Jang, Eun-Young Lee, Young Ho Byun, Eun-Ju Jung, Yoon Jae Lee, Yun Ha Lee, Kwang-Hee Lee, Jinhee Lee & Baik Lin Seong. (2014) Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Vaccine 32:5, pages 535-543.
Crossref
Kathleen L. Coelingh, Xionghua W. Wu, Raburn M. Mallory & Christopher S. Ambrose. (2014) An integrated multi-study analysis of serum HAI antibody responses to Ann Arbor strain live attenuated influenza vaccine in children and adults. Trials in Vaccinology 3, pages 150-153.
Crossref
Hong Jin & Kanta Subbarao. 2015. Influenza Pathogenesis and Control - Volume II. Influenza Pathogenesis and Control - Volume II 181 204 .
Meredith Stewart, Eric Dubois, Corinne Sailleau, Emmanuel Bréard, Cyril Viarouge, Alexandra Desprat, Richard Thiéry, Stéphan Zientara & Polly Roy. (2013) Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen. Vaccine 31:3, pages 553-558.
Crossref
Ronald B. Reisler, Paul H. Gibbs, Denise K. Danner & Ellen F. Boudreau. (2012) Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: Eastern equine and western equine encephalitis. Vaccine 30:50, pages 7271-7277.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.